The global Infection Control Market is experiencing steady growth as healthcare providers increasingly focus on patient safety, infection prevention, and maintaining hygienic medical environments. The rising number of surgical procedures, growing awareness of healthcare-associated infections (HAIs), and increasing adoption of advanced sterilization and disinfection technologies are supporting market expansion. According to Grand View Research, demand for infection control products and services is expected to increase as hospitals, laboratories, pharmaceutical companies, and medical device manufacturers strengthen their infection prevention practices. 

Key Market Statistics

• The global Infection Control Market was valued at USD 55.3 billion in 2025.

• The market is projected to reach USD 58.5 billion in 2026.

• By 2033, the market is expected to reach USD 90.0 billion.

• The market is projected to grow at a CAGR of 6.4% from 2026 to 2033.

• North America dominated the market with a 47.2% revenue share in 2025.

• Asia Pacific is expected to register the fastest regional growth, with a projected CAGR of 7.4% from 2026 to 2033. 

Download a free sample copy of the Infection Control Market report to understand detailed coverage and inclusions in the final report

Understanding the Infection Control Market

Infection control refers to the practices, technologies, equipment, and services used to prevent or reduce the transmission of infectious microorganisms in healthcare and other controlled environments. These solutions help protect patients, healthcare professionals, laboratory personnel, and medical products from contamination.

The market includes a broad range of products, including disinfectants, sterilization equipment, personal protective equipment (PPE), safety-enhanced medical devices, sterilization consumables, and infectious waste management solutions. Services such as contract sterilization and infectious waste disposal also play an important role in maintaining safe healthcare operations.

Hospitals and healthcare facilities rely on infection control measures in operating rooms, intensive care units, laboratories, patient wards, and instrument-processing departments. Medical device manufacturers and pharmaceutical companies also use sterilization and contamination-control procedures to maintain product safety and comply with applicable quality standards.

As healthcare systems expand and infection prevention becomes a greater operational priority, demand for reliable infection control products and services is expected to increase.

Rising Healthcare-Associated Infections Driving Market Growth

Healthcare-associated infections are among the major factors supporting the growth of the infection control industry. These infections may develop during medical treatment or healthcare delivery and can lead to complications, longer hospital stays, and higher treatment costs.

Surgical site infections, bloodstream infections, catheter-associated urinary tract infections, and respiratory infections create a need for effective prevention strategies. Healthcare facilities are therefore strengthening sterilization procedures, environmental cleaning, hand hygiene, protective equipment usage, and infection surveillance.

The growing number of surgical and clinical procedures is also increasing demand for sterile medical instruments, disinfectants, and single-use products. Effective infection control practices help healthcare providers reduce contamination risks and improve patient safety.

In addition, greater awareness of antimicrobial resistance is encouraging healthcare organizations to strengthen infection prevention programs. These developments are creating sustained demand for advanced infection control products and technologies.

Go Deeper! Ask Prism AI

about the Global Infection Control Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Increasing Demand for Sterilization and Disinfection Technologies

Sterilization and disinfection technologies are essential components of modern infection prevention. Hospitals, laboratories, and medical device manufacturers use these technologies to eliminate or reduce harmful microorganisms on medical instruments, equipment, and surfaces.

Traditional sterilization methods continue to play an important role, while automated systems and advanced disinfection technologies are creating additional market opportunities. These include low-temperature sterilization equipment, automated endoscope reprocessors, washer-disinfectors, and specialized decontamination systems.

Healthcare facilities are also exploring technologies such as UV-C disinfection systems and hydrogen peroxide vapor solutions to support environmental hygiene. These innovations can help standardize cleaning procedures and improve operational efficiency when used appropriately.

As medical procedures become more complex and healthcare facilities process increasing volumes of reusable instruments, the demand for reliable sterilization equipment and related consumables is expected to remain strong.

Consumables Segment Leads the Market

Based on type, the consumables segment accounted for 60.7% of the Infection Control Market revenue in 2025, making it the leading category. 

Its prominent position reflects the recurring need for products used in routine infection prevention and contamination control.

Important consumables include disinfectants, personal protective equipment, sterilization wraps and indicators, infectious waste disposal products, and safety-enhanced medical devices. Many of these products are regularly replaced, creating recurring demand from hospitals, laboratories, and other healthcare facilities.

The growing emphasis on disposable protective products and safe medical waste handling is also supporting this segment. Manufacturers are developing products designed to improve convenience, maintain hygiene standards, and reduce the risk of cross-contamination.

Meanwhile, the services segment is projected to grow at a CAGR of 8.6% during the forecast period, according to Grand View Research. 

Outsourced sterilization and infectious waste disposal services are becoming increasingly important for organizations seeking specialized capabilities and more efficient operations.

Hospitals Remain a Major End-Use Segment

Hospitals are a major source of demand for infection control products and services because they manage a high volume of patient admissions, surgical procedures, diagnostic tests, and invasive treatments.

The hospital segment accounted for 40.3% of market revenue in 2025. 

Hospitals require infection control solutions across operating theatres, intensive care units, emergency departments, laboratories, and central sterile services departments.

Common applications include instrument sterilization, surface disinfection, protective equipment usage, medical waste management, and the reprocessing of reusable medical devices. Healthcare providers must also establish staff training and monitoring procedures to encourage consistent compliance with infection prevention protocols.

Beyond hospitals, medical device companies, clinical laboratories, pharmaceutical companies, and other healthcare facilities contribute to market demand. These organizations require appropriate sterilization and contamination-control processes to protect personnel, patients, and products.

Looking for more specific insights? Customize this report to suite your business needs

Regional Outlook

North America dominated the global Infection Control Market with a 47.2% revenue share in 2025. Demand in the region is supported by established healthcare infrastructure, awareness of healthcare-associated infections, regulatory requirements, and the adoption of advanced sterilization and disinfection technologies.

The presence of established market participants and continued investment in healthcare equipment and research also support regional development. Hospitals and laboratories increasingly emphasize patient safety, infection surveillance, and compliance with infection prevention standards.

Asia Pacific is expected to experience the fastest regional growth, with a projected CAGR of 7.4% from 2026 to 2033. Expanding healthcare infrastructure, increasing healthcare expenditure, and improvements in medical facilities are creating opportunities throughout the region.

Countries such as India, China, Japan, and South Korea offer opportunities for infection control providers as healthcare systems modernize and demand for medical procedures increases. In India, rising patient volumes and the expansion of healthcare services are contributing to the need for improved hygiene, sterilization, and contamination prevention practices.

Competitive Landscape and Key Companies

The following are the leading companies in the infection control market. These companies collectively hold the largest market share and dictate industry trends.

• 3M

• Belimed AG

• O&M Halyard or its affiliates.

• GETINGE AB (publ) Corporate

• ASP

• MATACHANA

• Sterigenics U.S., LLC - A Sotera Health company

• MMM Group

• Medivators Inc.

• STERIS.

• Midmark Corporation.

• W&H

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Explore U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database